Drug Delivery Market (Targeted, Advanced) Worth $319B by 2021

USA - English

• India - English

PUNE, India, April 7, 2016 /PRNewswire/ --

Global industry analysis report on the advanced and targeted drug delivery market forecasts a 10.4% CAGR and $319 billion in worth by 2021 from $168 billion today for the sector. Supported by over 300 tables and figures, this 382 page report is an extensive industry analysis specifically written for C-Suite, VP and Higher executives within the Pharma and Biotech space.

Complete report on advanced and targeted drug delivery market spread across 382 pages, analysing major leaders and providing tables and figures is now available at http://www.reportsnreports.com/reports/522210-advanced-and-targeted-drug-delivery-market-segmentation-analysis-forecast-to-2021-nanoparticles-polymers-liposomes-micelles-nanoemulsions-dendrimers-monoclonal-antibodies-by-geography-therapeutic-area-and-stakeholder-environment.html.

The advanced and targeted drug delivery market is segmented and analysed through to 2021 with corresponding CAGR breakdown by:

• Technology (Nanoparticles, Polymers (micelles, dendrimers etc), Monoclonal antibodies, Gold nanoparticles-based drug delivery and imaging, Drug eluting stents)
• Geography (Global, USA, Europe, RoW)
• Therapeutic Area (Pulmonary, Ocular drug delivery, Ocular nano-based drug delivery implants, Drug Eluting Stents,
• Sub-Market Analysis (details below)

The monoclonal antibody market is further broken down and presented as the top selling mAbs by company, class and revenue through to 2021 with corresponding CAGR values.  Specific figures are given in relation to Humira, Remicade, Avastin, Rituxan, Soliris, Herceptin, Kadcyla, Perjeta, Lucentis, Xgeva/Prolia, Stelara and Tysarbi.

The global market for nano-based targeted drug delivery is presented by the following sub-markets liposomes, polymers (micelles, dendrimers etc) and gold nano-particles through to 2021 with corresponding CAGR figures.

The global pulmonary drug delivery market is analysed and presented as metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers through 2021 with corresponding CAGR data. This market is also divided into the following geographical regions USA, Europe, RoW, Global through 2021 with corresponding CAGR analysis. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=522210.

The PhD analysts identify breakthrough R&D papers and patents and delve into disruptive technical platforms that is revolutionising drug delivery systems. Business, financial and market analysis is performed on all data collated to yield robust figures and forecast through 2021 with CAGR values. Together, our scientific and business team provides you with their in depth knowledge, experience and perspective on the targeted drug delivery landscape.   Stake holder analysis of key players including innovators, developers and commercial partners is performed and an in depth chapter of 170 companies involved is presented.  The analysis includes details of how is breakthrough technology adoption is changing the drug delivery landscape and also how emerging products like hydrogels, PEGylated phospholipid nanocarriers and cyclodextrins are disrupting conventional markets.

By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy)

By Therapy (Cancer, Cardiovascular, Infectious Disease)

This report highlights a number of significant pharmacos and gives details of their operations, products, financials and business strategy are 23andMe, Abbott Laboratories, Abbott Molecular Inc., Admera Health (GENEWIZ), Affymetrix, Agendia, Alere, Amgen, Astex Pharmaceuticals, AstraZeneca, Atossa Genetics, Becton Dickenson, bioMerieux, BristolMyersSquibb, Cancer Genetics, Celera (Quest Diagnostics), Celldex Therapeutics , Claritas Genomics, CuraGen, Danaher (Leica Biosystems), deCode Genetics (Amgen), Foundation Medicine, EDP Biotech, Eli Lilly, ELDA BioTech, Eisai, Genelex, GlaxoSmithKline, Human Longevity Inc (Cypher Genomics), HalioDx, Ikonisys, Illumina, InterGenetics, Johnson & Johnson, LabCorp, Life Technologies, Merck, MDxHealth, MolecularMD Corporation, Monogram Biosciences, Myriad, Nodality, Novartis MDx, Orion Genomics, Oxford BioTherapeutics, NanoString Technologies, Pfizer, Qiagen, Roche Molecular Diagnostics, Sanofi, SensiGen, Siemens Healthcare Diagnostics, Takeda, Thermo Fisher Scientific, Transgenomic, Ventana (Roche), Vermillion (Ciphergen) and Vertex Pharmaceuticals.

The report provides an in-depth understanding of the global personalized medicine market and its environment. Provides the current market facts, figures and product lines of key players in the industry. The emerging trends in key markets such as the US, UK, Germany and France. Knowledge of how the personalized medicine market will integrate into the global healthcare market. Provides the technical insights into new generation sequencing technologies and ultra-high throughput sequencing. Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies. FDA approved pharmacogenetic tests and recognized biomarkers. The information on key government and regulatory policies is also included. Strategies on how to adapt and restructure current business models to this industry

This report will tell you if the companies mentioned are strong, competitive players; Pooling their resources for specific growth and therapeutic areas; Investing strategically in R&D; Have a history of strategic M&A activity.

Explore other reports on drug delivery market at http://www.reportsnreports.com/tags/drug-delivery-market-research.html.

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
[email protected]

Connect With Us on:
Facebook: https://www.facebook.com/ReportsnReports/
LinkedIn: https://www.linkedin.com/company/reportsnreports
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
RSS/Feeds:   http://www.reportsnreports.com/feed/l-latestreports.xml

SOURCE ReportsnReports